Patents by Inventor Qiang Xia
Qiang Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210002948Abstract: An L-shaped metal mesh door and a manufacturing method thereof are provided. The metal mesh door includes an L-shaped metal mesh and a strip-shaped metal engagement slot. Two metal engagement slots are connected at a corner through L-shaped metal members inserted into a cavity of the metal engagement slot. The metal mesh is embedded in the metal engagement slot. The manufacturing method includes following steps. Manufacturing the metal mesh material by folding a metal mesh material into a 90° L shape. Manufacturing the metal engagement slot chamfering the two metal engagement slots by 45° at the corner, assembling the metal engagement slots through the L-shaped metal members inserted into the square cavity, and then fixing them with screws. Embedding the metal mesh fixedly in the engaging opening of the metal engagement slot, and filling a plastic soft strip in the circular cavity for fixing.Type: ApplicationFiled: May 25, 2018Publication date: January 7, 2021Applicant: ZBOM HOME COLLECTION CO., LTD.Inventors: Hejun Ye, Qiang Xia, Anyong Wang, Wenjuan Li, Yuanyuan Song, Dan Wang
-
Publication number: 20190167003Abstract: A door type of kitchen cabinet includes a door panel and an edge-sealing handle mounted on an upper end of the door panel. The edge-sealing handle includes an edge-sealing plate located above a top portion of the door panel, a buckle plate disposed above a front end of the edge-sealing plate, a decorative plate disposed below the front end of the edge-sealing plate, a closing strip disposed at a bottom portion of the decorative plate, and a fixing leg disposed under a middle section of the edge-sealing plate and embedded in the top portion of the door panel. The top portion of the door panel is provided with a mounting groove corresponding to the fixing leg.Type: ApplicationFiled: May 25, 2018Publication date: June 6, 2019Applicant: ZBOM HOME COLLECTION CO., LTD.Inventors: Qiang Xia, Anyong Wang, Dan Wang
-
Publication number: 20180321782Abstract: The present disclosure provides display panel and display device. The display panel includes: a plurality of sub-pixel units defined by the plurality of data lines intersecting the plurality of scanning lines in an insulation manner. The plurality of sub-pixel units constitutes a plurality of rendering pixel units arranged in an array. Each of the plurality of rendering pixel units includes at least two adjacent sub-pixel units in a row of sub-pixel units, and a number of sub-pixel units included in each of the plurality of rendering pixel units is smaller than a total number of colors corresponding to color resists in the display panel. In each row of sub-pixel units, at least two rendering pixel units of the plurality of rendering pixel units are disposed between two adjacent touch lines. In each column of rendering pixel units, each rendering pixel unit performs color rendering with its adjacent sub-pixel unit.Type: ApplicationFiled: June 28, 2018Publication date: November 8, 2018Applicant: Shanghai AVIC OPTO Electronics Co., Ltd,Inventors: Feng QIN, Shou Fu JIAN, Zhi Qiang XIA, Zhao Keng CAO
-
Patent number: 8802721Abstract: The invention relates to compounds of structural formulas (I) and (XVI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, Z, L, L2, R1, R2, R3, R21, n, q, and t are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.Type: GrantFiled: January 25, 2006Date of Patent: August 12, 2014Assignee: Synta Pharmaceuticals Corp.Inventors: Lijun Sun, Shoujun Chen, Jun Jiang, Zhi-Qiang Xia, Yu Xie, Chih-Yi Yu
-
Patent number: 8710083Abstract: The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein Y, L, X1, X2, Z, R3, R4, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.Type: GrantFiled: March 29, 2010Date of Patent: April 29, 2014Assignee: Synta Pharmaceuticals Corp.Inventors: Jun Jiang, Zhi-Qiang Xia, Junyi Zhang, Gary Bohnert, Shoujun Chen, Yu Xie
-
Patent number: 8680100Abstract: The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included.Type: GrantFiled: December 1, 2009Date of Patent: March 25, 2014Assignee: Synta Pharmaceuticals Corp.Inventors: Jun Jiang, Teresa Kowalczyk-Przewloka, Stefan M. Schweizer, Zhi-Qiang Xia, Shoujun Chen, Christopher Borella, Lijun Sun
-
Publication number: 20130338162Abstract: Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.Type: ApplicationFiled: July 29, 2013Publication date: December 19, 2013Applicant: SYNTA PHARMACEUTICALS CORP.Inventors: Lijun Sun, Keizo Koya, Shoujun Chen, Zachary Demko, Zhi-Qiang Xia
-
Patent number: 8592486Abstract: The invention relates to compounds of structural formulas (I), (VII) and (XI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, X3, Y, Z, L, R1, R2, R3, R18 and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.Type: GrantFiled: May 14, 2012Date of Patent: November 26, 2013Assignee: Synta Pharmaceuticals Corp.Inventors: Lijun Sun, Shoujun Chen, Zhi-Qiang Xia, Jun Jiang, Yu Xie, Junyi Zhang
-
Patent number: 8497272Abstract: Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.Type: GrantFiled: August 20, 2007Date of Patent: July 30, 2013Assignee: Synta Pharmaceuticals Corp.Inventors: Lijun Sun, Keizo Koya, Shoujun Chen, Zachary Demko, Zhi-Qiang Xia
-
Patent number: 8461208Abstract: Disclosed are bis(thio-hydrazide amide) disalts and pharmaceutical compositions thereof. Also disclosed are methods of using bis(thio-hydrazide amide) disalts to treat cancer.Type: GrantFiled: October 14, 2011Date of Patent: June 11, 2013Assignee: Synta Pharmaceuticals Corp.Inventors: Keizo Koya, Lijun Sun, Elena Kostik, Farid Vaghefi, Shoujun Chen, Noriaki Tatsuta, Guiqing Liang, Takayo Inoue, Zhi-Qiang Xia
-
Publication number: 20120225883Abstract: The invention relates to compounds of structural formulas (I), (VII) and (XI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, X3, Y, Z, L, R1, R2, R3, R18 and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.Type: ApplicationFiled: May 14, 2012Publication date: September 6, 2012Applicant: Synta Pharmaceuticals Corp.Inventors: Lijun Sun, Shoujun Chen, Zhi-Qiang Xia, Jun Jiang, Yu Xie, Junyi Zhang
-
Patent number: 8202999Abstract: The invention relates to compounds of structural formulas (I), (VII) and (XI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, X3, Y, Z, L, R1, R2, R3, R18 and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.Type: GrantFiled: January 6, 2006Date of Patent: June 19, 2012Assignee: Synta Pharmaceuticals Corp.Inventors: Lijun Sun, Shoujun Chen, Zhi-Qiang Xia, Jun Jiang, Yu Xie, Junyi Zhang
-
Publication number: 20120065206Abstract: The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included.Type: ApplicationFiled: December 1, 2009Publication date: March 15, 2012Applicant: SYNTA PHARMACEUTICALS CORP.Inventors: Jun Jiang, Teresa Kowalczyk-Przewloka, Stefan M. Schweizer, Zhi-Qiang Xia, Shoujun Chen, Christopher Borella, Lijun Sun
-
Publication number: 20120035266Abstract: Disclosed are bis(thio-hydrazide amide) disalts and pharmaceutical compositions thereof. Also disclosed are methods of using bis(thio-hydrazide amide) disalts to treat cancer.Type: ApplicationFiled: October 14, 2011Publication date: February 9, 2012Applicant: Synta Pharmaceuticals Corp.Inventors: Keizo KOYA, Lijun Sun, Elena Kostik, Farid Vaghefi, Shoujun Chen, Noriaki Tatsuta, Guiqing Liang, Takayo Inoue, Zhi-Qiang Xia
-
Patent number: 8048925Abstract: Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): Y is a covalent bond or a substituted or unsubstituted straight chained hydrocarbyl group. R1-R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or R1 and R3 taken together with the carbon and nitrogen atoms to which they are bonded, and/or R2 and R4 taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. Z is —O or —S. M+ is a pharmaceutically acceptable monovalent cation and M2+ is a pharmaceutically acceptable divalent cation. Also, disclosed are pharmaceutical compositions comprising a bis(thio-hydrazide amide) disalt described above. Further disclosed are methods of treating a subject with cancer. The methods comprise the step of administering an effective amount of a bis(thio-hydrazide amide) disalt described above.Type: GrantFiled: August 30, 2010Date of Patent: November 1, 2011Assignee: Synta Pharmaceuticals Corp.Inventors: Keizo Koya, Lijun Sun, Elena Kostik, Farid Vaghefi, Shoujun Chen, Noriaki Tatsuta, Guiqing Liang, Takayo Inoue, Zhi-Qiang Xia
-
Publication number: 20110245262Abstract: Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.Type: ApplicationFiled: August 20, 2007Publication date: October 6, 2011Inventors: Lijun Sun, Keizo Koya, Shoujun Chen, Zachary Demko, Zhi-Qiang Xia
-
Publication number: 20100324143Abstract: Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): Y is a covalent bond or a substituted or unsubstituted straight chained hydrocarbyl group. R1-R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or R1 and R3 taken together with the carbon and nitrogen atoms to which they are bonded, and/or R2 and R4 taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. Z is —O or —S. M+ is a pharmaceutically acceptable monovalent cation and M2+ is a pharmaceutically acceptable divalent cation. Also, disclosed are pharmaceutical compositions comprising a bis(thio-hydrazide amide) disalt described above. Further disclosed are methods of treating a subject with cancer. The methods comprise the step of administering an effective amount of a bis(thio-hydrazide amide) disalt described above.Type: ApplicationFiled: August 30, 2010Publication date: December 23, 2010Inventors: Keizo Koya, Lijun Sun, Elena Kostik, Farid Vaghefi, Shoujun Chen, Noriaki Tatsuta, Guiqing Liang, Takayo Inoue, Zhi-Qiang Xia
-
Patent number: D865135Type: GrantFiled: June 29, 2017Date of Patent: October 29, 2019Assignee: ZBOM HOME COLLECTION CO., LTDInventors: Qiang Xia, Anyong Wang
-
Patent number: D865136Type: GrantFiled: June 29, 2017Date of Patent: October 29, 2019Assignee: ZBOM HOME COLLECTION CO., LTD.Inventors: Qiang Xia, Anyong Wang
-
Patent number: D865921Type: GrantFiled: November 21, 2017Date of Patent: November 5, 2019Assignee: ZBOM HOME COLLECTION CO., LTD.Inventors: Qiang Xia, Anyong Wang, Hejun Ye, Wenjuan Li, Dan Wang, Rongkang Zhu